Simon Senanu: Understanding the Extrinsic Coagulation Pathway
Simon Senanu, Medical Laboratory Scientist at Perkins Medical Centre, shared a post on LinkedIn:
”Prothrombin Time (PT) and INR – Understanding the Extrinsic Pathway
Hemostasis involves a coordinated sequence of reactions that lead to clot formation and stabilization.
One of the most commonly used laboratory tests for evaluating this process is the Prothrombin Time (PT).
PT assesses the extrinsic and common pathways of the coagulation cascade, making it an essential test in diagnosing bleeding disorders and monitoring anticoagulant therapy.
What Is Prothrombin Time (PT)?
Prothrombin Time measures the time required for plasma to clot after the addition of tissue factor (thromboplastin) and calcium.
This test evaluates the activity of several clotting factors, including:
- Factor I (Fibrinogen)
- Factor II (Prothrombin)
- Factor V
- Factor VII
- Factor X
Because Factor VII belongs to the extrinsic pathway, PT is particularly sensitive to abnormalities affecting this pathway.
Principle of the Test In the laboratory:
- Citrated plasma is obtained from the patient sample
- Tissue thromboplastin and calcium are added
- The time taken for fibrin clot formation is measured
The result is reported in seconds and often converted to the International Normalized Ratio (INR) for standardization.
What Is INR?
The International Normalized Ratio (INR) was developed to standardize PT results between different laboratories and reagents.
INR allows clinicians to monitor patients receiving oral anticoagulants such as warfarin more reliably.
Typical values include:
- Normal individuals: INR ≈ 0.8 – 1.2
- Patients on warfarin therapy: INR 2.0 – 3.0 (depending on indication)
Causes of Prolonged PT
Prolonged PT may occur in conditions affecting the extrinsic or common coagulation pathways, including:
- Vitamin K deficiency
- Liver disease
- Warfarin therapy
- Disseminated intravascular coagulation (DIC)
- Factor VII deficiency
- Severe clotting factor depletion
Because many clotting factors are synthesized in the liver, PT is often used as a marker of hepatic synthetic function.
Pre-Analytical Considerations
Accurate PT results depend on proper sample handling. Important factors include:
- Correct blood-to-anticoagulant ratio (9:1)
- Proper mixing of citrated blood
- Avoiding hemolysis or clot formation in the tube
- Prompt plasma separation
Errors during collection or processing may lead to falsely prolonged results.
Laboratory Takeaway
Prothrombin Time is a key tool for evaluating extrinsic pathway defects and monitoring anticoagulant therapy.
When interpreted alongside other coagulation tests such as Activated Partial Thromboplastin Time (aPTT) and D-dimer, it helps provide a clearer picture of the patient’s hemostatic status.”

Other posts featuring Simon Senanu on Hemostasis Today.
-
Mar 16, 2026, 14:27Mahesan Subramaniam: Why Messy Spaces Impact Women’s Stress Levels More Than Men’s
-
Mar 16, 2026, 14:21Marlies Alvarenga: Balancing the Scales in Women’s Cardiovascular Health
-
Mar 16, 2026, 13:32Filippo Cademartiri: Inflammation vs Cholesterol as Driver of Residual ASCVD Risk
-
Mar 16, 2026, 13:12Mariia Kumskova։ New Insights Into Platelet Dysfunction in Ehlers-Danlos Syndrome
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes